DNAM-1 plays a pivotal role in NK cell-mediated tumor immunosurveillance, as studies have demonstrated the expression of DNAM-1 ligands CD155 and CD112 across a wide spectrum of solid tumors and hematologic malignancies. Here, NECTIN2 is linked to neoplasm.